Colorectal cancer patients of African ancestry less likely to have targetable gene mutations?
Colorectal cancer patients of African ancestry are less likely to have tumors that respond well to two important classes of newer treatments: immunotherapy and targeted therapy, according to an analysis of genetic data from 4,441 people treated for colorectal cancer at Memorial Sloan Kettering Cancer Center in New York. These treatments work better against tumors […]